Nicholas A.J. Botwood, Head of R&D, CMO: Syndax Pharmaceuticals SNDX Buy · Filed 25/05/19

Trade details

Type: Insider buy
Amount: $105,885
Shares · price: 11,765 sh · $9.00 a share
Held after: 35,165 sh
Stock: Syndax Pharmaceuticals SNDX
Person: Nicholas A.J. BotwoodHead of R&D, CMO
Trade date: 25/05/16
Filed: 25/05/19
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +50.3%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/16~25/06/15

Nicholas A.J. Botwood's recent trades

Nicholas A.J. BotwoodHead of R&D, CMO
Sell10b5-1 planSyndax Pharmaceuticals
Sell10b5-1 plan
Syndax Pharmaceuticals
SNDX
$617K
34,280 sh
$617K
Filed 06/12
Traded 06/11
Nicholas A.J. BotwoodHead of R&D, CMO
Sell10b5-1 planSyndax Pharmaceuticals
Sell10b5-1 plan
Syndax Pharmaceuticals
SNDX
$566.6K
31,235 sh
$566.6K
Filed 06/12
Traded 06/12
Nicholas A.J. BotwoodHead of R&D, CMO
Planned sale10b5-1 planSyndax Pharmaceuticals
Planned sale10b5-1 plan
Syndax Pharmaceuticals
SNDX
$566.7K
31,235 sh
$566.7K
Filed 06/12
Traded 06/12
Nicholas A.J. BotwoodHead of R&D, CMO
Planned sale10b5-1 planSyndax Pharmaceuticals
Planned sale10b5-1 plan
Syndax Pharmaceuticals
SNDX
$609.4K
34,280 sh
$609.4K
Filed 06/11
Traded 06/11